Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

19.9K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.9K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.4K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

1.8K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

4.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.5K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

87.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
87.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis.

Brain : a journal of neurology·2025
Same author

MiR-146b-5p Decreases Cytokine Release From Astrocytes and Preserves Oligodendrocyte Progenitor Cell Complexity During Inflammation.

The European journal of neuroscience·2025
Same author

An Overview of Multiple Sclerosis Care in Rural and Urban Newfoundland and Labrador.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2025
Same author

Investigating T-cell-derived extracellular vesicles as biomarkers of disease activity, axonal injury, and disability in multiple sclerosis.

Clinical and experimental immunology·2025
Same author

A miR-383-5p Signaling Hub Coordinates the Axon Regeneration Response to Inflammation.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2024
Same author

Bruton Tyrosine Kinase Inhibition Decreases Inflammation and Differentially Impacts Phagocytosis and Cellular Metabolism in Mouse- and Human-derived Myeloid Cells.

ImmunoHorizons·2024

Related Experiment Video

Updated: Feb 28, 2026

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

21.9K

Bruton's Tyrosine Kinase-Going Beyond the B Cell.

Rochelle Y Benoit1, Sheila Loshi1, Craig S Moore1

  • 1Division of Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.

Immunology
|February 26, 2026
PubMed
Summary

Bruton's Tyrosine Kinase (BTK) regulates myeloid cell functions, impacting innate immunity. BTK inhibitors show promise for treating inflammatory diseases beyond B cell cancers.

Keywords:
Bruton's tyrosine kinaseautoimmunityinflammationinnate immunitymacrophage

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.4K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.7K

Related Experiment Videos

Last Updated: Feb 28, 2026

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

21.9K
Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.4K
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.7K

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Bruton's Tyrosine Kinase (BTK) is crucial for B cell signaling and increasingly recognized for its role in myeloid cell regulation.
  • BTK influences key pathways in monocytes, macrophages, microglia, and granulocytes, affecting phagocytosis, inflammation, and metabolism.
  • While BTK inhibitors (BTKis) are approved for B cell cancers, their efficacy extends to autoimmune and neuroinflammatory disorders.

Purpose of the Study:

  • To review and compare how BTK inhibition affects inflammatory phenotypes and functions across different myeloid-derived cell subsets.
  • To provide cell-specific insights into BTK's role as a regulator of innate immunity.
  • To explore the translational potential of BTKis in various inflammatory diseases.

Main Methods:

  • Literature review and synthesis of existing research on BTK function in myeloid cells.
  • Comparative analysis of BTK inhibition effects across distinct myeloid cell types.
  • Examination of molecular pathways modulated by BTK in innate immune cells.

Main Results:

  • BTK plays a significant role in regulating inflammatory responses and functions within diverse myeloid cell populations.
  • BTK inhibition alters phenotypes related to phagocytosis, inflammatory signaling (NFκB, STAT3, NLRP3), and cell metabolism in myeloid cells.
  • Evidence supports the therapeutic potential of BTKis in conditions like rheumatoid arthritis, IgA nephropathy, multiple sclerosis, and chronic spontaneous urticaria.

Conclusions:

  • BTK is a central regulator of innate immunity and myeloid cell function, with cell-specific regulatory roles.
  • Understanding cell-specific effects of BTK inhibition is key to expanding its therapeutic applications.
  • BTK inhibitors hold significant translational promise for a wide range of immune-mediated and inflammatory diseases.